Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy among female prisoners in Brazil

Parente EDO, Leal M, Kendall C, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2022; 27 (12) : 4485-4492.
Download PDF
Publication

Leprosy chemoprophylaxis of household contacts: A survey of Canadian infectious disease and tropical medicine specialists.

Boodman C, Keystone J, Bogoch I. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada. 2022; 7 (1) : 8-13.
Download PDF
Publication

Pathogenicity and virulence of Mycobacterium leprae

Sugawara-Mikami M, Tanigawa K, Kawashima A, et al. Virulence. 2022; 13 (1) : 1985-2011.
Download PDF
Publication

Implementation approaches for leprosy prevention with single-dose rifampicin: A support tool for decision making.

Ellen F, Tielens K, Fenenga C, et al. PLoS neglected tropical diseases. 2022; 16 (10) : e0010792.
Download PDF
Publication

Leprosy Caused by Mycobacterium lepromatosis.

Romero-Navarrete M, Arenas R, Han X, et al. American journal of clinical pathology. 2022;
Publication

Factors associated with the development of leprosy in Brazilian contacts: a systematic review

Alecrin ESD, Oliveira ALGD, Guimarães NS, et al. FapUNIFESP (SciELO). Revista do Instituto de Medicina Tropical de São Paulo. 2022;
Download PDF
Publication

Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission

World Health Organization . Weekly epidemiological record. 2022; 97 (36) : 429-452.
Download PDF
Publication

Epidemiological trends of leprosy and case detection delay in East Hararghe Zone, Ethiopia: A baseline survey

Mamo E, Bobosha K, Legesse M, et al. Lepra. Leprosy Review. 2022; 93 (3) : 184-196.
Download PDF
Publication

PEP4LEP research and its contribution to capacity building

Mieras L. Lepra. Leprosy Review. 2022; 93 (3) : 180-183.
Download PDF
Publication

Post-elimination scenario of leprosy in a tertiary care hospital in South India

Monteiro R, Bhat M R. International League of Dermatological Societies. Community Skin Health. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 15
  • Next page ››
Subscribe to Transmission

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD